about
Steroid ligands bind human sex hormone-binding globulin in specific orientations and produce distinct changes in protein conformationDehydroepiandrosterone modulates nuclear factor-kappaB activation in hippocampus of diabetic ratsExtracorporeal shock waves enhance normal fibroblast proliferation in vitro and activate mRNA expression for TGF-beta1 and for collagen types I and III.O-Glycosylation of human sex hormone-binding globulin is essential for inhibition of estradiol-induced MCF-7 breast cancer cell proliferation.The androgen receptor CAG repeat: a modifier of carcinogenesis?Epigenetics modifications and therapeutic prospects in human thyroid cancer.Valproic Acid, a Histone Deacetylase Inhibitor, in Combination with Paclitaxel for Anaplastic Thyroid Cancer: Results of a Multicenter Randomized Controlled Phase II/III Trial.Emerging molecular therapies of advanced thyroid cancer.Evidence that fibulin family members contribute to the steroid-dependent extravascular sequestration of sex hormone-binding globulin.The pan-histone deacetylase inhibitor LBH589 (panobinostat) alters the invasive breast cancer cell phenotype.Histone deacetylase inhibition affects sodium iodide symporter expression and induces 131I cytotoxicity in anaplastic thyroid cancer cells.Dysregulation of SREBP2 induces BACE1 expression.Cytotoxic activity of the histone deacetylase inhibitor panobinostat (LBH589) in anaplastic thyroid cancer in vitro and in vivo.Valproic acid restores ER alpha and antiestrogen sensitivity to ER alpha-negative breast cancer cells.Molecular mechanisms of the D327N SHBG protective role on breast cancer development after estrogen exposure.Valproic acid enhances tubulin acetylation and apoptotic activity of paclitaxel on anaplastic thyroid cancer cell lines.High energy shock waves activate 5'-aminolevulinic Acid and increase permeability to Paclitaxel: antitumor effects of a new combined treatment on anaplastic thyroid cancer cells.Valproic acid, a histone deacetylase inhibitor, enhances sensitivity to doxorubicin in anaplastic thyroid cancer cells.Estrogen receptor-beta is expressed in stromal cells of fibroadenoma and phyllodes tumors of the breast.Valproic acid induces apoptosis and cell cycle arrest in poorly differentiated thyroid cancer cells.Cytotoxicity of anticancer drugs incorporated in solid lipid nanoparticles on HT-29 colorectal cancer cell line.Valproic acid induces the expression of the Na+/I- symporter and iodine uptake in poorly differentiated thyroid cancer cells.Sex steroid binding protein is a negative modulator of estrogen-induced breast cancer cell growth.Effect of n-3 fatty acids on patients with advanced lung cancer: a double-blind, placebo-controlled study.Pro-oxidant effect of dehydroepiandrosterone in rats is mediated by PPAR activation.Oxidative stress impairs skeletal muscle repair in diabetic rats.Up-regulation of advanced glycated products receptors in the brain of diabetic rats is prevented by antioxidant treatment.Oxidative stress triggers cardiac fibrosis in the heart of diabetic rats.AGEs/RAGE complex upregulates BACE1 via NF-κB pathway activation.Doxorubicin-Loaded Nanobubbles Combined with Extracorporeal Shock Waves: Basis for a New Drug Delivery Tool in Anaplastic Thyroid Cancer.MCF-7 cell progesterone receptor (PGR) is additionally modulated by sex steroid binding protein (SBP) and its membrane receptor (SBP-R) through cAMP and PKA.Altered expression of androgen-receptor isoforms in human colon-cancer tissues.Extracorporeal shock waves modulate myofibroblast differentiation of adipose-derived stem cells.Histone Deacetylase Inhibition Modulates E-Cadherin Expression and Suppresses Migration and Invasion of Anaplastic Thyroid Cancer CellsOxidative Stress-Dependent Impairment of Cardiac-Specific Transcription Factors in Experimental DiabetesSomatic alterations of the androgen receptor CAG repeat in human colon cancer delineate a novel mutation pathway independent of microsatellite instabilityEstradiol induction of cAMP in breast cancer cells is mediated by foetal calf serum (FCS) and sex hormone-binding globulin (SHBG)Dehydroepiandrosterone administration counteracts oxidative imbalance and advanced glycation end product formation in type 2 diabetic patients
P50
Q27639175-7E6D5A3A-CA22-44DE-91C0-1188F4B16370Q28574008-30D6AF81-C98D-4402-B205-69E2E4F176C9Q30483225-3DAEC61E-761B-4BF7-903F-C24466CFC753Q34130969-19DCE290-78DA-4042-AE9A-44408369DAA4Q34772530-AD6D5012-737E-424A-8ED9-DA3CD94ECEA8Q35971504-B50670E2-D169-4C56-ACD4-E7495CB6700CQ37330090-97DDF228-D622-4854-8DB6-E4B9085F774AQ37696635-A4ECF47B-663C-4FCC-A42F-F0D3275897F7Q38314406-F2A9A093-2EE7-44C6-90B7-4A0BED96613BQ39040551-46FA185A-2925-4885-BF1D-527E899E44CCQ39175368-332C6F4A-E732-4F38-8D8D-3D2814F42436Q39513077-C2CAC8DC-855C-4063-BA13-E076FDDE3EB2Q39576722-08B72EA7-FAB0-41B7-958D-31B72945872EQ39796457-8E8AFB67-F1F2-4D93-AF14-BBFE3D585857Q39988197-0CD076B2-7CBF-49C0-81B7-8D36F3FB8F5CQ40072387-8627B3BA-713A-46AA-831F-4FF46BD659DCQ40168104-1476A067-BFB4-4199-9D5D-B22A838B7AE2Q40211424-7B4DCB3E-6ADF-4A57-8504-B973BAAD6DAFQ40300902-6842B4EB-246A-4F49-BDEA-A4162DEE0B41Q40483365-A363A2B5-AB03-4BFA-A55C-CB13A98AD52AQ40510362-2B43D0C7-BA06-4848-AE1B-66816325D0E5Q40592037-B92C6375-0CA9-4BAA-BD34-B35AA09B7457Q40999417-56FEA580-4FFE-45A1-9697-A8A5CD308C15Q43668998-F34731DA-867C-4A2C-B9D5-43057F7602A6Q44448175-A6EC9BE9-FC9B-4FED-B226-CF1897DD92B0Q44816760-DDD0D9C8-8389-430B-A27B-2BA305D664C5Q46706048-00CB2E8D-FA4D-49C4-8C57-910F43697D52Q46977339-74002A4B-AA17-42A1-91AB-FFB6F52B0FD0Q48123320-B46F94CF-06B9-42E2-8B55-BA0726FA43FAQ50204367-572CF2EE-31FE-4112-887E-DAD47212F24BQ51030394-AF99EE78-A1F0-4D5E-8012-7AB150F50D39Q53411360-76126E98-E666-47BA-9E0F-5153F66C2250Q53800156-9DD73B53-246D-4EE4-8126-381A7F9EB56AQ59836005-E5C269E9-1349-416C-B904-C52EE42E3686Q60321191-62DDCCE1-67C4-4E93-835F-537792101481Q61449459-E5E9A8F3-9873-47D7-89F2-D30ACA1450E4Q61449462-2171EFBC-3CBA-4D21-8C2C-FC2266373A50Q80807747-AB5A8B9A-5FCF-4C36-9F34-379C02D22C2B
P50
description
researcher ORCID id 0000-0002-1170-8245
@en
wetenschapper
@nl
name
Maria Graziella Catalano
@ast
Maria Graziella Catalano
@en
Maria Graziella Catalano
@es
Maria Graziella Catalano
@nl
type
label
Maria Graziella Catalano
@ast
Maria Graziella Catalano
@en
Maria Graziella Catalano
@es
Maria Graziella Catalano
@nl
prefLabel
Maria Graziella Catalano
@ast
Maria Graziella Catalano
@en
Maria Graziella Catalano
@es
Maria Graziella Catalano
@nl
P106
P1153
7102930063
P21
P31
P496
0000-0002-1170-8245